secwatch.observer — SEC 8-K summary
======================================

Issuer:     Marker Therapeutics, Inc. (MRKR)
CIK:        0001094038
Form:       8-K
Filed at:   2026-02-09T23:59:59+00:00
Accession:  0001104659-26-012063
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.08, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Marker Therapeutics sets 2026 annual meeting for May 1; shareholder proposals due March 9
--------------------------------------------------------------------------------

- 2026 Annual Meeting scheduled for May 1, 2026, moving more than 30 days from 2025 meeting date.
- Shareholder proposals under Rule 14a-8 must be received by March 9, 2026, at company's Houston offices.
- Record date and meeting details to be included in the upcoming proxy statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1094038/000110465926012063/0001104659-26-012063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1094038/000110465926012063/tm265663d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-012063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer